References:
[1].
AyaluA. Reda1
and Sibhatu Biadgilign2 Determinants of Adherence to Antiretroviral Therapy
among HIV-Infected Patients in Africa: AIDS Research
and Treatment Volume 2012, Article ID 574656, doi:10.1155/2012/574656
[2]. Anant Gokarn, Meenakshi Gangadhar Narkhede, Geeta
Shrikar Pardeshi, Mohan Kondiba Doibale Adherence to Antiretroviral Therapy JAPI
• DECEMBER 2012 VOL. 60
[3].
Chirundu D,
Tapesana S. Magande P.N. Madzingaidzo G. Mduluza T. Does Shot Message Reminders
Improve ART Adherence? Randomised Control Trial among HIV Clients Kadoma
Zimbabwe KAMPS STUDY Protocol Texila International Journal of Clinical
Research, Volume 4, Issue 1, Jun 2017
[4]. Chesney
MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, Wu AW. Self-reported
adherence to antiretroviral medications among participants in HIV clinical
trials: the AACTG adherence instruments. Patient Care Committee & Adherence
Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group
(AACTG). AIDS Care. 2000 Jun; 12(3):255-66.
[5].
Eliud Wekesa: ART adherence in resource
poor settings in sub-Saharan Africa: a multidisciplinary review;
[6]. Garcia
et al (2003) An Adherence Trilogy is Essential for Long Term HAART Success: The
Brazilian Journal of Infectious Diseases 2003; 7(5):307-314.).
[7]. Garcia
et, al. An Adherence Trilogy is
Essential for Long Term HAART Success: The Brazilian Journal of Infectious
Diseases 2003; 7(5):307-314.).
[8]. Gloria Nkomo: A Study to
Explore factors that Influence Adherence to Antiretroviral Therapy among HIV
and AIDS Adult Patients Attending Antiretroviral Clinic at Beatrice Infectious
Disease Hospital Harare Zimbabwe.: University of South Africa 2014).
[9]. H.
Liu, C. E. Golin, L. G. Miller et al., “A comparison study of multiple measures
of adherence to HIV protease inhibitors,” Annals of Internal Medicine,
vol. 134, no. 10, pp. 968–977, 2001.
[10]. Harriet
Okatch: Apparent Antiretroviral Over adherence by Pill Count is associated with
HIV Treatment Failure in Adolescents: J. Acquir Immune Defic Syndr
2016:542-545.
[11]. Jeannie
K Lee Karen A Grace Terri G Foster Monica J Crawley Goldina I Erowele Hazel J
Sun Phuong T Turner Lance E Sullenberger Allen J Taylor; How should we measure
medication adherence in clinical trials and practice? Therapeutics and Clinical
Risk Management 2007:3(4) 685–690.
[12]. Lawrence
Mbuagbaw, Lehana Thabane, Pierre Ongolo-Zogo, David Yondo, Stephen Noorduyn,
Marek Smieja, and Lisa Dolovich: Trends and determining factors associated with
adherence to antiretroviral therapy (ART) in Cameroon: a systematic review and
analysis of the CAMPS trial, AIDS Research and Therapy 2012, 9:37.
[13].
Low-Beer S, Yip B, O’Shaughnessy
MV, Hogg RS, Montaner JS. Adherence to
triple therapy and viral load response, J Acquir Immune Defic Syndr,
2000, vol. 23 (pg. 360-1).
[14]. Muringazuva,
Caroline (2015) Factors associated with Adherence to
Anti-retroviral therapy among HIV clients, Kadoma city, Zimbabwe 2015. Research Council of Zimbabwe.
[15]. Muyingo SK, Walker AS, Reid A, et al. Patterns of individual
and population-level adherence to antiretroviral therapy and risk factors for
poor adherence in the first year of the DART trial in Uganda and Zimbabwe. J Acquir Immune Defic Syndr. 2008;
48:468–475.
[16]. Margaret
A. Chesney
Factors Affecting Adherence to Antiretroviral Therapy Clin Infect Dis (2000) 30 (Supplement_2):
S171-S176.
[17]. Mary Ellen Wewers and Nancy K. Lowe: A Critical Review of Visual Analogue Scales in the Measurement of Clinical Phenomena: Research in Nursing &
Health, 1990, 13, 227-236).
[18]. Marelich
W. D, K. Johnston Roberts; Murphy, D.A., and T. Callari (2002) “HIV/AIDS
patient involvement in antiretroviral treatment decisions. AIDS Care 14 (1):
17-26.
[19]. Marukutira,
TA. 2012. Factors influencing adherence to antiretroviral in adolescents at
Botswana Baylor Children’s Clinical Centre of Excellence: a qualitative study.
MA (Health Studies) Dissertation. University of South Africa, Pretoria. From:
http://uir:unisa.ac.za/bitstream/handle/0500/6036 (accessed 22 March 2013).
[20]. Nadia
Dowshen; Lisa M Kuhns; Amy Johnson; Brian James Holoyda; Robert Garofalo:
Improving Adherence to Antiretroviral Therapy for Youth Living with HIV/AIDS: A
Pilot Study Using Personalized, Interactive, Daily Text Message Reminders, J Med Internet
Res 2012;14(2): e51.
[21]. Nyi
Nyi Naing Determination of Sample Size Malaysian Journal of Medical Sciences,
Vol. 10, No. 2, July 2003 (84-86).
[22]. Ndiaye,
Maimouna; Nyasulu, Peter; Nguyen, Hoang; Lowenthal, Elizabeth D.; Gross,
Robert; Mills, Edward J.; and Nachega, Jean B., "Risk Factors for
Suboptimal Antiretroviral Therapy Adherence in HIV-Infected Adolescents in
Gaborone, Botswana: A Pilot Cross- Sectional Study" (2013). Botswana-UPenn
Scholarly.
[23].
N.C Talam, P. Gatongi, J. Rotich; S.
Kimaiyo. Factors Affecting Antiretroviral Drug Adherence among HIV/AIDS Adults
patients attending HIV/AIDS Clinic at Moi Teaching and Referral Hospital.
Eldoret Kenya. East African Journal of Public Health Volume 5 Number 2 August
2008.
[24]. P. T.
Nieuwkerk and F. J. Oort, “Self-reported adherence to antiretroviral therapy
for HIV-1 infection and virologic treatment response: a meta-analysis,” Journal
of Acquired Immune.
[25]. Parienti JJ, Verdon R, et al. The Pills Identification Test:
A tool to assess adherence to antiretroviral therapy. JAMA. 2001; 285: 412.
[26]. Paterson DL, Swindells S, Mohr J, et al.
Adherence to protease inhibitor therapy and outcomes in patients with HIV
infection Ann Intern Med, 2000, vol. 133 (pg. 21-30).
[27].
Ross AJ, Aung M, Campbell L, Ogunbanjo
GA. Factors that positively influence adherence to antiretroviral therapy by
HIV and/or AIDS patients and their caregivers. Afr J Prm Health Care Fam Med.
2011; 3(1), Art. #196, 5 pages. doi: 10.4102/phcfm. v3i1.196.
[28]. Stirratt MJ, Dunbar-Jacob J, Crane HM, et al. Self-report
measures of medication adherence behaviour: recommendations on optimal use. Translational Behavioral Medicine.
2015; 5(4):470-482. doi: 10.1007/s13142-015-0315-2.
[29]. Sodergard B, Halvarsson M, Tully M. P, Mindouri S,
Nordstrom L, Lindback S, Sonnerborg A, Kettis Lindblad A. Adherence to
treatment in Swedish HIV infected patients. Journal of Clinical Pharmacy
and Therapeutics 2006; 31:605-616).
[30]. Steel G., Nwokike J., Joshi M. 2007. Development of
a Multi-Method Tool to Measure ART Adherence in Resource-Constrained Settings:
The South Africa Experience. Submitted to the U.S. Agency for International
Development by the Rational Pharmaceutical Management Plus Program. Arlington,
VA: Management Sciences for Health.
[31]. Sasaki
et al. Adherence to antiretroviral therapy (ART) during the early months of
treatment in rural Zambia: influence of demographic characteristics and social
surroundings of patients, Annals of Clinical Microbiology and Antimicrobials
2012, 11:34).
[32]. Sasaki
et al. Adherence to antiretroviral therapy (ART) during the early months of
treatment in rural Zambia: influence of demographic characteristics and social
surroundings of patients, Annals of Clinical Microbiology and Antimicrobials
2012, 11:34).
[33]. Sellier
P. Clevenbergh L: Comparative evaluation of adherence to antiretroviral therapy
in Sub-Suharans African native HIV Infected patients in France and Africa:
Clinical Infections Diseases Vol. 43 no 5. 2006.
[34]. Shah B, Walshe L,
Saple DG, Mehta SH, Ramnani JP, Kharkar RD, Bollinger RC, Gupta A. Adherence to antiretroviral therapy and virologic suppression among HIVinfected persons receiving care in private clinics in Mumbai, India. Clin Infect
Dis. 2007 May 1; 44(9):1235-44. Epub
2007 Mar 22.
[35]. UNAIDS;
2030 ending the AIDS epidemic Fact Sheet. UNAIDS June 2017.
[36]. Woke
FI. Socio-demographic determinant of ART adherence South Africa 2009-2014.
Webmed Central AIDS 2015; 6(6): WMC004924.
[37]. Wasti
SP, Simkhada P, Randall J, Freeman JV, van Teijlingen E (2012) Factors
Influencing Adherence to Antiretroviral Treatment in Nepal: A Mixed Methods
Study. PLoS ONE 7(5): e35547. doi: 10.1371/journal.pone.0035547.
[38]. WHO-
Adherence to long-term therapies: evidence for action. WHO 2003
[39]. Zoran Bursac et, al. Purposeful selection of
variables in logistic regression: Source Code for Biology and Medicine 2008,
3:17.
[40]. Ziad
El-Khatib, Anna Mia Ekstrom, Ashraf Coovadia, Elaine J Abrams, Max Petzold,
David Katzenstein, Lynn Morris and Louise Kuhn; Adherence and virologic suppression during the first 24 weeks on
antiretroviral therapy among women in Johannesburg, South Africa - a
prospective cohort study: MC
Public Health 201111:88.